[3-[2-(2,6-二氧代哌啶-4-基)-1-羟基-乙基]-1,5-二甲基-4-氧代-环己基]乙酸酯
- 中文名称:
- [3-[2-(2,6-二氧代哌啶-4-基)-1-羟基-乙基]-1,5-二甲基-4-氧代-环己基]乙酸酯
- 中文别名:
- 2,6-Piperidinedione, 4-[2-[5-(acetyloxy)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-, [1S-[1.α.(S*),3.β.,5.β.]]
- 英文名称:
- 2,6-Piperidinedione,4-[(2R)-2-[(1S,3S,5R)-5-(acetyloxy)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-
- 英文别名:
- 2,6-Piperidinedione, 4-[2-[5-(acetyloxy)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-, [1S-[1.α.(S*),3.β.,5.β.]]-;
AXM;
Antibiotic from streptomyces albulus;
Streptovitacin E 73;
Cycloheximide,4-acetoxy-(E-B);
Acetyloxycycloheximide;
Antibiotic SF-2441;
Acetoxycycloheximide;
Cycloheximide,acetoxy
- CAS No.:
- 2885-39-4
- 分 子 式:
-
C17H25NO6
- 分 子 量:
- 339.43
- 精确分子量:
- 339.16800
- PSA:
- 109.77000
- InChI:
- The Key: UFDHNJJHPSGMFX-SQUSCZTCSA-N3
- 安全术语:
- Deadly poison by ingestion, intravenous, intraperitoneal, and subcutaneous routes. Human mutation data reported. When heated to decomposition it emits toxic fumes such as NOx.
- 分子结构式:
-

- SDS:
- 查看
[3-[2-(2,6-二氧代哌啶-4-基)-1-羟基-乙基]-1,5-二甲基-4-氧代-环己基]乙酸酯 物化性质
- 密度:
- 1.24g/cm3
- 沸点:
- 529.4ºC at 760mmHg
- 闪点:
- 274ºC
- 存储条件/存储方法:
- 库房通风低温干燥,与氧化剂、食品添加剂、酸类分开存放
[3-[2-(2,6-二氧代哌啶-4-基)-1-羟基-乙基]-1,5-二甲基-4-氧代-环己基]乙酸酯 毒理性
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- MA5075000
- CHEMICAL NAME :
- Glutarimide,
3-(2-hydroxy-2-(5-hydroxy-3,5-dimethyl-2-oxocyclohexy
l)ethyl)-, 5-acetate
- CAS REGISTRY NUMBER :
- 2885-39-4
- LAST UPDATED :
- 199009
- DATA ITEMS CITED :
- 7
- MOLECULAR FORMULA :
- C17-H25-N-O6
- MOLECULAR WEIGHT :
- 339.43
- WISWESSER LINE NOTATION :
- T6VMVTJ EYQ1- BL6VTJ DOV1 D1 F1
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 158 ug/kg
- TOXIC EFFECTS :
- Behavioral - somnolence (general depressed activity)
Gastrointestinal - hypermotility, diarrhea
Skin and Appendages - hair
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 170 ug/kg
- TOXIC EFFECTS :
- Behavioral - somnolence (general depressed activity)
Gastrointestinal - hypermotility, diarrhea
Skin and Appendages - hair
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 190 ug/kg
- TOXIC EFFECTS :
- Behavioral - somnolence (general depressed activity)
Gastrointestinal - hypermotility, diarrhea
Skin and Appendages - hair
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 19 mg/kg
- TOXIC EFFECTS :
- Behavioral - somnolence (general depressed activity)
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Mammal - dog
- DOSE/DURATION :
- 920 ug/kg
- TOXIC EFFECTS :
- Behavioral - convulsions or effect on seizure threshold
Behavioral - coma
Lungs, Thorax, or Respiration - other changes
MUTATION DATA
- TYPE OF TEST :
- DNA inhibition
- TEST SYSTEM :
- Human HeLa cell
- DOSE/DURATION :
- 1 umol/L
- REFERENCE :
- BCPCA6 Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House,
Fairview Park, Elmsford, NY 10523) V.1- 1958- Volume(issue)/page/year:
14,205,1965
[3-[2-(2,6-二氧代哌啶-4-基)-1-羟基-乙基]-1,5-二甲基-4-氧代-环己基]乙酸酯 上游产品